MyFinsight
Home
Blog
About
Contact
Proceeds from sales and
maturities of investments
$33,187K
Net cash provided by
investing activities
$22,455K
Canceled cashflow
$10,732K
Net (decrease)
increase in cash, cash...
-$3,116K
Canceled cashflow
$22,455K
Stock-based compensation
expense
$1,916K
Other
-$84K
Depreciation expense
$49K
Purchases of investments
$10,726K
Purchases of property and
equipment
$6K
Net cash used in
operating activities
-$25,571K
Canceled cashflow
$2,049K
Net loss
-$22,969K
Prepaid expenses and
other current assets
$1,947K
Accounts payable
-$1,868K
Accrued expenses
-$346K
Net amortization of
premiums and discounts on...
$346K
Operating right-of-use
assets and operating...
$144K
Back
Back
Cash Flow
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
source: myfinsight.com